Stryker Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +8.8%
EBITDA: +40.2%
EBIT: +3.6%
EPS: +16.4%
Free cash flow: +27.8%
Operating cash flow: +25.3%

Forward estimates

Revenue: +12.3%
EBITDA: +5.5%
EPS: +83.1%

Three-year CAGR

Revenue: +10.8%
EBITDA: +16.3%
EBIT: +9.4%
Net income: +11.2%
EPS: +10.9%
Free cash flow: +28.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.